Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radical Hysterectomy and Tailored Chemo-Radiation vs Primary Chemo-Radiation in Stage IB2 Cervical Cancer
NCT00054067Phase 3Terminated
- Sponsor
- GOG Foundation
- Start
- Feb 2003
- Primary completion
- Apr 2005
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of cisplatin in Cervical Cancer (CC), sponsored by GOG Foundation. Started Feb 2003; status: terminated.
02
Drugs
cisplatin
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT00054067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00054067.